Open AccessAltered FOXO1 Transcript Levels in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
Author(s) -
Chia-Chen Kuo,
Szu-Yuan Lin
Publication year - 2007
Publication title -
molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.844
H-Index - 118
eISSN - 1528-3658
pISSN - 1076-1551
DOI - 10.2119/2007-00021.kuo
Subject(s) - foxo1 , peripheral blood mononuclear cell , rheumatoid arthritis , immunology , pathogenesis , medicine , arthritis , lupus erythematosus , autoimmunity , transcription factor , biology , gene , immune system , antibody , in vitro , biochemistry
FOXO forkhead transcription factors play an important role in controlling lymphocyte activation and proliferation. To evaluate the possibility that FOXO transcriptional expression is dysregulated in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients, we determined the quantities of FOXO1, FOXO3a, and FOXO4 transcripts in peripheral blood mononuclear cells (PBMCs) from normal controls as well as from SLE and RA patients. Results showed that FOXO1 and FOXO3a are dominant FOXO factors at the transcript level in PBMCs. Statistical analysis showed that the FOXO1 transcript levels in RA patients and in SLE patients with active disease activity were significantly lower than those in normal controls, and the FOXO1 transcript levels were inversely correlated with lupus disease activity. In contrast, the differences in FOXO3a and FOXO4 transcript levels between normal controls and patients were not significant. These data suggest that the transcriptional dysregulation in FOXO1 is possibly linked to the pathogenesis of SLE and RA.